Artal Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-42,750
| Closed | -$4.56M | – | 127 |
|
|
2020
Q3 | $4.56M | Sell |
42,750
-15,900
| -27% | -$1.69M | 0.11% | 88 |
|
|
2020
Q2 | $8.89M | Sell |
58,650
-1,350
| -2% | -$205K | 0.25% | 62 |
|
|
2020
Q1 | $5M | Hold |
60,000
| – | – | 0.21% | 63 |
|
|
2019
Q4 | $10.1M | Buy |
60,000
+10,000
| +20% | +$1.69M | 0.39% | 44 |
|
|
2019
Q3 | $9.29M | Buy |
50,000
+5,000
| +11% | +$929K | 0.37% | 41 |
|
|
2019
Q2 | $10.3M | Sell |
45,000
-5,000
| -10% | -$1.14M | 0.42% | 41 |
|
|
2019
Q1 | $10.5M | Hold |
50,000
| – | – | 0.43% | 39 |
|
|
2018
Q4 | $5.75M | Hold |
50,000
| – | – | 0.21% | 42 |
|
|
2018
Q3 | $11.5M | Hold |
50,000
| – | – | 0.3% | 28 |
|
|
2018
Q2 | $11.2M | Hold |
50,000
| – | – | 0.24% | 28 |
|
|
2018
Q1 | $11.4M | Hold |
50,000
| – | – | 0.14% | 24 |
|
|
2017
Q4 | $13.1M | Buy |
50,000
+30,000
| +150% | +$7.86M | 0.2% | 18 |
|
|
2017
Q3 | $4.49M | Hold |
20,000
| – | – | 0.08% | 38 |
|
|
2017
Q2 | $5.47M | Buy |
+20,000
| New | +$5.47M | 0.1% | 37 |
|